Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0055 | 0.0065 | 1 |
Onchocerca volvulus | Ribonuclease H1 homolog | 0.058 | 0.2527 | 1 |
Trypanosoma brucei | unspecified product | 0.0629 | 0.2757 | 0.2728 |
Mycobacterium leprae | PROBABLE FATTY-ACID-CoA LIGASE FADD7 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) | 0.0055 | 0.0065 | 0.5 |
Trypanosoma brucei | retrotransposon hot spot protein 4 (RHS4), interrupted | 0.0629 | 0.2757 | 0.2728 |
Toxoplasma gondii | ribonuclease HI protein | 0.058 | 0.2527 | 0.5 |
Schistosoma mansoni | phosphoglucomutase | 0.058 | 0.2527 | 0.2497 |
Entamoeba histolytica | acyl-CoA synthetase, putative | 0.0055 | 0.0065 | 0.5 |
Echinococcus granulosus | insulin receptor | 0.0056 | 0.0072 | 0.013 |
Trypanosoma cruzi | ribonuclease H1, putative | 0.058 | 0.2527 | 1 |
Entamoeba histolytica | acyl-coA synthetase, putative | 0.0055 | 0.0065 | 0.5 |
Schistosoma mansoni | tyrosine kinase | 0.0086 | 0.0211 | 0.0172 |
Brugia malayi | AMP-binding enzyme family protein | 0.0055 | 0.0065 | 0.01 |
Loa Loa (eye worm) | TK/EGFR protein kinase | 0.0166 | 0.0587 | 1 |
Brugia malayi | AMP-binding enzyme family protein | 0.0055 | 0.0065 | 0.01 |
Schistosoma mansoni | tyrosine kinase | 0.0086 | 0.0211 | 0.0172 |
Schistosoma mansoni | tyrosine kinase | 0.0056 | 0.0072 | 0.0033 |
Plasmodium vivax | acyl-CoA synthetase, putative | 0.0041 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0055 | 0.0065 | 0.1101 |
Entamoeba histolytica | acyl-CoA synthetase, putative | 0.0055 | 0.0065 | 0.5 |
Trypanosoma brucei | ingi protein (ORF1) | 0.0629 | 0.2757 | 0.2728 |
Echinococcus multilocularis | 0.005 | 0.0043 | 0.0014 | |
Treponema pallidum | ribonuclease H (rnhA) | 0.058 | 0.2527 | 0.5 |
Mycobacterium ulcerans | long-chain-fatty-acid--CoA ligase | 0.0055 | 0.0065 | 1 |
Echinococcus granulosus | melanoma receptor tyrosine protein kinase | 0.0091 | 0.0237 | 0.0793 |
Brugia malayi | RNase H family protein | 0.058 | 0.2527 | 1 |
Giardia lamblia | Ribonuclease H | 0.058 | 0.2527 | 1 |
Echinococcus granulosus | epidermal growth factor receptor | 0.0091 | 0.0237 | 0.0793 |
Brugia malayi | RNase H family protein | 0.058 | 0.2527 | 1 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0629 | 0.2757 | 0.2728 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0055 | 0.0065 | 1 |
Trypanosoma brucei | ingi protein (ORF1) | 0.0629 | 0.2757 | 0.2728 |
Schistosoma mansoni | tyrosine kinase | 0.0086 | 0.0211 | 0.0172 |
Echinococcus multilocularis | insulin growth factor 1 receptor beta | 0.0056 | 0.0072 | 0.013 |
Echinococcus granulosus | insulin growth factor 1 receptor beta | 0.0056 | 0.0072 | 0.013 |
Loa Loa (eye worm) | hypothetical protein | 0.0055 | 0.0065 | 0.1101 |
Brugia malayi | Protein kinase domain containing protein | 0.0056 | 0.0072 | 0.013 |
Echinococcus granulosus | ribonuclease H1 | 0.058 | 0.2527 | 1 |
Schistosoma mansoni | tyrosine kinase | 0.0056 | 0.0072 | 0.0033 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD2 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0055 | 0.0065 | 0.074 |
Wolbachia endosymbiont of Brugia malayi | ribonuclease HI | 0.058 | 0.2527 | 0.5 |
Schistosoma mansoni | tyrosine kinase | 0.0091 | 0.0237 | 0.0198 |
Brugia malayi | Furin-like cysteine rich region family protein | 0.0166 | 0.0587 | 0.2202 |
Trichomonas vaginalis | ribonuclease H1, putative | 0.058 | 0.2527 | 1 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0055 | 0.0065 | 1 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | 0.0227 | 0.0874 | 1 |
Schistosoma mansoni | phosphoglucomutase | 0.058 | 0.2527 | 0.2497 |
Mycobacterium ulcerans | long-chain-fatty-acid-CoA ligase | 0.0055 | 0.0065 | 1 |
Schistosoma mansoni | phosphoglucomutase | 0.058 | 0.2527 | 0.2497 |
Brugia malayi | AMP-binding enzyme family protein | 0.0055 | 0.0065 | 0.01 |
Chlamydia trachomatis | acylglycerophosphoethanolamine acyltransferase | 0.0041 | 0 | 0.5 |
Brugia malayi | RNase H family protein | 0.058 | 0.2527 | 1 |
Echinococcus granulosus | epidermal growth factor receptor | 0.0166 | 0.0587 | 0.2202 |
Echinococcus multilocularis | epidermal growth factor receptor | 0.0166 | 0.0587 | 0.2202 |
Trypanosoma brucei | ribonuclease H1 | 0.058 | 0.2527 | 0.2497 |
Schistosoma mansoni | tyrosine kinase | 0.0166 | 0.0587 | 0.055 |
Echinococcus multilocularis | insulin receptor | 0.0056 | 0.0072 | 0.013 |
Mycobacterium tuberculosis | Probable chain -fatty-acid-CoA ligase FadD13 (fatty-acyl-CoA synthetase) | 0.0055 | 0.0065 | 0.074 |
Leishmania major | ribonuclease H1, putative | 0.058 | 0.2527 | 1 |
Echinococcus multilocularis | epidermal growth factor receptor | 0.0091 | 0.0237 | 0.0793 |
Echinococcus multilocularis | ribonuclease H1 | 0.058 | 0.2527 | 1 |
Onchocerca volvulus | 0.0055 | 0.0065 | 0.01 | |
Loa Loa (eye worm) | TK/INSR protein kinase | 0.0056 | 0.0072 | 0.1229 |
Mycobacterium ulcerans | hypothetical protein | 0.0055 | 0.0065 | 1 |
Mycobacterium leprae | PROBABLE FATTY-ACID-CoA LIGASE FADD2 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) | 0.0055 | 0.0065 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0055 | 0.0065 | 0.1101 |
Mycobacterium ulcerans | long-chain fatty-acid CoA ligase | 0.0055 | 0.0065 | 1 |
Trypanosoma cruzi | ribonuclease H1, putative | 0.058 | 0.2527 | 1 |
Schistosoma mansoni | tyrosine kinase | 0.0091 | 0.0237 | 0.0198 |
Trypanosoma brucei | RNA helicase, putative | 0.2173 | 1 | 1 |
Mycobacterium tuberculosis | Possible maturase | 0.0049 | 0.004 | 0.0455 |
Plasmodium falciparum | acyl-CoA synthetase | 0.0041 | 0 | 0.5 |
Mycobacterium ulcerans | fatty-acid-CoA ligase | 0.0055 | 0.0065 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
CNS activity (functional) | = 1 | CNS activity was measured by the ability to restore the anticonvulsant effect of methazolamide in reserpine treated rats | ChEMBL. | 6788956 |
Hormonal activity (functional) | = 0.2 | Compound was evaluated in vivo for its ability to stimulate release of [125I]-labeled T3 and T4 after administration of varying doses | ChEMBL. | 6788956 |
pKa (ADMET) | = 6.18 | Acid dissociation constant was measured | ChEMBL. | 6788956 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.